News

• October, 14   2009
  Nerviano Medical Sciences: the SIF – Farmindustria prize for pharmacological research awarded to Paolo Cappella
  
  
• October, 8   2009
  In JCO, Danusertib results of a Phase 1 trial. Phase 2 in patients with lung cancer and other solid tumors ongoing.
  
  
• September, 25   2009
  Dr. Artur Góra guest at the Oncology Seminar at Nerviano Medical Sciences
  
  
• May, 22   2009
  Prof Menico Rizzi guest at the Oncology Seminars at Nerviano Medical Sciences
  
  
• May, 19   2009
  30 MILLION FOR NMS: THE RECAPITALIZATION HAS BEEN COMPLETED.
  
  
• May, 13   2009
  Nerviano Medical Sciences receives approval from the FDA to enter Phase I clinical trials for their Polo Like Kinase (PLK) inhibitor